Cell & Gene Therapy
Cell & Gene Therapy
Marken has a unique cell and gene therapy offering, supporting both clinical and commercial therapies with multi-dimensional logistics and global cryogenic network to deliver tomorrow’s advanced therapy lifelines.
Go beyond with us
Our ever-evolving portfolio includes secure, closed loop supply chain services, end-to-end visibility through data-driven tracking solutions and 24/7 cell and gene control tower monitoring oversight. As the leading partner to safeguard these ultra-sensitive, time and temperature-critical treatments, we go beyond cell and gene orchestration to support patients who rely on us to anticipate, innovate and deliver.
Related resources
From innovation to access: Bridging cold chain precision logistics for advanced therapies & cold chain precision logistics for advanced therapies
31 July 2025
Marken knows that when seconds matter, failure is never an option. In this high-impact podcast, Rohin Iyer, Senior Director of…
T-cells and Trade Wars: Navigating Uncertainty in the Advanced Therapy Supply Chain
24 June 2025
In an insight-packed webinar and panel discussion hosted by BSMA, industry leaders Dan Bell (Chief Strategy Officer, Marken), Dr. Rohin…
Marken’s Precision Logistics Accelerate Life-Changing Luxturna Therapy Delivery to Patient in South Korea
5 June 2025
When a South Korean patient needed a life-changing gene therapy, Marken orchestrated an international distribution strategy under the strictest regulatory…
Precision Logistics for Complex Therapies
5 June 2025
Advancements in cell and gene therapies (CGTs) have revolutionized treatment for complex diseases, exemplified by Emily Whitehead’s remarkable journey as…
Precision Logistics: A Patient-First Model for Advanced Therapies
3 June 2025
In this exclusive ISCT TV interview, Marken’s Senior Director, Global Cell and Gene Therapy Operations, Rohin Iyer, PhD, shares how Marken…
Does your supply chain hold up under pressure for high-risk temperature-critical shipments?
28 May 2025
Does your supply chain partner deliver under pressure? In today’s high-stakes healthcare environment, defined by the relentless pace of pharmaceutical…
Scaling Cold Chain Precision Logistics for the Future of Advanced Therapeutics
2 May 2025
Advanced therapies represent a new era in medicine offering potentially curative treatments for previously intractable diseases. However, their complex manufacturing…
Marken’s Precision Logistics Expedites Delivery of Critical Gene Therapies to Japan
17 April 2025
Tasked with the delivery of two ultra-sensitive gene therapies to Japan – treatments targeting vision loss that required continous -80°C…
Precision Logistics: Optimizing the Supply Chain for Advanced Therapies
5 March 2025
Cell and Gene Therapies (CGTs) are revolutionizing medicine by offering long-term remission and even cures for previously untreatable diseases. However,…
Mastering the Advanced Therapy Supply Chain
29 October 2024
The field of Advanced Therapy Medicinal Products (ATMPs) has seen monumental advancements in recent years, offering groundbreaking treatments for a…
Orchestrating Outcomes for Logistics – Driving Digitalization and Patient-Centric Innovation in Pharma Supply Chains – Part 2
20 September 2024
Part 2 of our Orchestrating Outcomes for Logistics interview series highlights how building resilience into every link of the supply chain drives precision, progress and patient-centric innovation
Orchestrating Outcomes for Logistics – Driving Digitalization and Patient-Centric Innovation in Pharma Supply Chains – Part 1
20 September 2024
To drive supply chain digitalization, it’s essential to leverage data not only to address immediate challenges but to anticipate and prevent disruptions
Delivering What Matters
Experience the capabilities of three UPS companies uniting as one. Together, we are Marken UPS Healthcare Precision Logistics.
Login and quick links